Recently, structurally similar pyrrolopyrimidines were found to reduce TDP-43 phosphorylation, a pathological hallmark of amyotrophic lateral sclerosis (ALS) [10]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.